scholarly article | Q13442814 |
P356 | DOI | 10.1017/S1462399411002080 |
P698 | PubMed publication ID | 22152163 |
P50 | author | Thomas Thum | Q42250812 |
P2093 | author name string | Johan M Lorenzen | |
Janine C Spiegel | |||
P2860 | cites work | Detection of microRNA expression in human peripheral blood microvesicles | Q21144210 |
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells | Q24300024 | ||
Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 | ||
A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development | Q24620604 | ||
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice | Q24623247 | ||
bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA | Q24647092 | ||
Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma | Q24648226 | ||
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes | Q24651802 | ||
Requirement of bic/microRNA-155 for normal immune function | Q24656120 | ||
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
Requirement of the chemokine receptor CXCR3 for acute allograft rejection | Q24676298 | ||
MicroRNA-155 is induced during the macrophage inflammatory response | Q24683841 | ||
MicroRNA profiling of the murine hematopoietic system | Q24811302 | ||
MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice | Q28115423 | ||
miR-181a is an intrinsic modulator of T cell sensitivity and selection | Q28294631 | ||
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 | Q28510667 | ||
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
Regulation of the germinal center response by microRNA-155 | Q29547777 | ||
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | Q29614238 | ||
microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells | Q29619307 | ||
MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 | ||
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas | Q29622911 | ||
Leukocyte migration and graft-versus-host disease | Q30479618 | ||
Cloning and expression of human GTDC1 gene (glycosyltransferase-like domain containing 1) from human fetal library | Q33201143 | ||
miRNA profiling of naïve, effector and memory CD8 T cells. | Q33302117 | ||
Improved RNA quality and TaqMan Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials | Q33318568 | ||
MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression | Q33426268 | ||
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis | Q34044475 | ||
Identification of a microRNA signature of renal ischemia reperfusion injury | Q34069581 | ||
Molecules and mechanisms of the graft-versus-leukaemia effect | Q34318010 | ||
Transcription and processing of human microRNA precursors | Q34378218 | ||
An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. | Q34625798 | ||
Pervasive roles of microRNAs in cardiovascular biology | Q34775686 | ||
Graft-versus-leukemia effects of transplantation and donor lymphocytes | Q34887477 | ||
Dynamic regulation of miRNA expression in ordered stages of cellular development. | Q35677284 | ||
Derivation and function of small interfering RNAs and microRNAs | Q35739888 | ||
miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely | Q35758613 | ||
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR | Q35848083 | ||
Functions of toll-like receptors: lessons from KO mice | Q35871614 | ||
Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies | Q35901997 | ||
A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection | Q36372711 | ||
Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts | Q77349284 | ||
Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? | Q80369913 | ||
Microarray analysis of MicroRNA expression in acute rejection after renal transplantation | Q80887475 | ||
MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p | Q84218089 | ||
Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease | Q85224456 | ||
Hematopoietic stem-cell transplantation | Q36461248 | ||
Regulation of inflammatory responses by IL-17F | Q36639980 | ||
Immunobiology of allogeneic hematopoietic stem cell transplantation | Q36665305 | ||
Noninvasive prediction of organ graft rejection and outcome using gene expression patterns | Q36677509 | ||
Antibody-mediated renal allograft rejection: diagnosis and pathogenesis | Q36759900 | ||
Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition | Q36985824 | ||
Gene expression profiling in autoimmune noninfectious uveitis disease | Q37074127 | ||
MicroRNA expression profiles predictive of human renal allograft status | Q37146807 | ||
MicroRNAs: novel regulators in cardiac development and disease | Q37176880 | ||
microRNAs and the immune response | Q37178538 | ||
Patterns of microRNA expression characterize stages of human B-cell differentiation. | Q37187523 | ||
The emerging role of microRNAs in immune cell development and differentiation | Q37585613 | ||
MicroRNAs as immune regulators: implications for transplantation | Q37701938 | ||
Late complications after hematopoietic stem cell transplantation | Q37810122 | ||
MicroRNAs as mediators and therapeutic targets in chronic kidney disease | Q37855524 | ||
The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target? | Q37937045 | ||
Smad3-mediated upregulation of miR-21 promotes renal fibrosis | Q38388639 | ||
The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection | Q40244088 | ||
Essential flexibility in the T-cell recognition of antigen | Q40973329 | ||
Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice | Q42472990 | ||
Comparison of different miR-21 inhibitor chemistries in a cardiac disease model | Q42580017 | ||
T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. | Q42687667 | ||
Netrin-1: a novel universal biomarker of human kidney injury | Q42974204 | ||
Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury | Q43278313 | ||
Differential expression of microRNAs in hematopoietic cell lineages | Q43735294 | ||
Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients | Q44164490 | ||
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts | Q44469254 | ||
The natural history of chronic allograft nephropathy | Q44688416 | ||
MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation | Q45345507 | ||
Interleukin-17 and kidney allograft outcome | Q45349027 | ||
MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice | Q47776609 | ||
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. | Q54356342 | ||
Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. | Q54363176 | ||
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. | Q54408211 | ||
Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. | Q54793731 | ||
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia | Q57234164 | ||
P921 | main subject | microRNA | Q310899 |
organ transplantation | Q69253852 | ||
P304 | page(s) | e37 | |
P577 | publication date | 2011-12-08 | |
P1433 | published in | Expert Reviews in Molecular Medicine | Q15755244 |
P1476 | title | Role of microRNAs in immunity and organ transplantation | |
P478 | volume | 13 |
Q104289866 | Advances of miRNAs in kidney graft injury |
Q36261525 | Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation |
Q38870288 | Epigenetics in ENS development and Hirschsprung disease |
Q36082945 | Identification of Circulating miRNAs in a Mouse Model of Nerve Allograft Transplantation under FK506 Immunosuppression by Illumina Small RNA Deep Sequencing |
Q30456341 | MiRNAs in kidney transplantation: potential role as new biomarkers |
Q36307846 | MicroRNA expression profiles in human CD3+ T cells following stimulation with anti-human CD3 antibodies |
Q47699114 | MicroRNAs are potential objective and early biomarkers for acute rejection of transplanted limbs in a rat model. |
Q38244516 | MicroRNAs in kidney transplantation |
Q97589581 | MicroRNAs in solid organ and vascularized composite allotransplantation: Potential biomarkers for diagnosis and therapeutic use |
Q86870797 | No evidence for a genetic association of IRF4 with systemic lupus erythematosus in a Chinese population |
Q41676628 | Plasma microRNAs Are Potential Biomarkers of Acute Rejection After Hindlimb Transplantation in Rats |
Q89029625 | Role of miR-449a in the Activation and Metabolism of CD4+ T Cells |
Q37573199 | Transcriptional Perturbations in Graft Rejection |
Q42281859 | Upregulation of microRNA 142-3p in the peripheral blood and urinary cells of kidney transplant recipients with post-transplant graft dysfunction |
Q48112727 | Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation. |
Q40064947 | miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation |